Hernando_2012_Mol.Pharmacol_82_550

Reference

Title : Contribution of subunits to Caenorhabditis elegans levamisole-sensitive nicotinic receptor function - Hernando_2012_Mol.Pharmacol_82_550
Author(s) : Hernando G , Berge I , Rayes D , Bouzat C
Ref : Molecular Pharmacology , 82 :550 , 2012
Abstract :

Caenorhabditis elegans muscle contains seven different nicotinic receptor (AChR) subunits, five of which have been shown to be components of adult levamisole-sensitive AChRs (L-AChRs). To elucidate the reason for such subunit diversity, we explore their functional roles in larva 1 (L1) muscle cells. Single-channel and macroscopic current recordings reveal that the alpha-type LEV-8 subunit is a component of native L1 L-AChRs but behaves as a nonessential subunit. It plays a key role in maintaining a low rate and extent of desensitization of L-AChRs. In the absence of the alpha-type ACR-8 subunit, L-AChR channel properties are not modified, thus indicating that ACR-8 is not a component of L1 L-AChRs. Together with our previous findings, this study reveals that L1 muscle cells express a main L-AChR type composed of five different subunits: UNC-38, UNC-63, UNC-29, LEV-1, and LEV-8. Analysis of a double lev-8; acr-8-null mutant, which shows an uncoordinated and levamisole-resistant phenotype, reveals that ACR-8 can replace LEV-8 in its absence, thus attributing a functional role to this subunit. Docking into homology modeled L-AChRs proposes that ACh forms the typical cation-pi interaction, suggests why levamisole is less efficacious than ACh, and shows that ACR-8 can form activatable binding-sites, thus opening doors for elucidating subunit arrangement and anthelmintic selectivity.

PubMedSearch : Hernando_2012_Mol.Pharmacol_82_550
PubMedID: 22734069

Related information

Citations formats

Hernando G, Berge I, Rayes D, Bouzat C (2012)
Contribution of subunits to Caenorhabditis elegans levamisole-sensitive nicotinic receptor function
Molecular Pharmacology 82 :550

Hernando G, Berge I, Rayes D, Bouzat C (2012)
Molecular Pharmacology 82 :550